tiprankstipranks
Advertisement
Advertisement

VSTM Stock Latest News

3 Best Stocks to Buy Today, According to Top Analysts
Market News3 Best Stocks to Buy Today, According to Top Analysts
4d ago
BBOT
VSTM
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
PremiumRatings
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
6d ago
VSTM
Verastem announces two-year median follow-up data on AVMAPKI FAKZYNJA combo
PremiumThe Fly
Verastem announces two-year median follow-up data on AVMAPKI FAKZYNJA combo
6d ago
VSTM
Verastem assumed with a Buy at Jefferies
PremiumThe Fly
Verastem assumed with a Buy at Jefferies
17d ago
VSTM
Verastem management to meet with Cantor
PremiumThe Fly
Verastem management to meet with Cantor
21d ago
VSTM
Verastem assumed with a Buy at BTIG
PremiumThe FlyVerastem assumed with a Buy at BTIG
1M ago
VSTM
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
Premium
Ratings
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
1M ago
VSTM
Verastem Earnings Call: Early Momentum, Long Runway Risks
Premium
Company Announcements
Verastem Earnings Call: Early Momentum, Long Runway Risks
1M ago
VSTM
Verastem: Differentiated Next‑Generation KRAS G12D Inhibitor VS‑7375 Underpins Buy Rating on Compelling Early Clinical Data
PremiumRatings
Verastem: Differentiated Next‑Generation KRAS G12D Inhibitor VS‑7375 Underpins Buy Rating on Compelling Early Clinical Data
1M ago
VSTM
Verastem price target raised to $18 from $16 at Alliance Global
PremiumThe Fly
Verastem price target raised to $18 from $16 at Alliance Global
1M ago
VSTM
Verastem: Strong Commercial Uptake and Expanding RAS/MAPK Oncology Pipeline Underpin Buy Rating and $18 Target
PremiumRatings
Verastem: Strong Commercial Uptake and Expanding RAS/MAPK Oncology Pipeline Underpin Buy Rating and $18 Target
1M ago
VSTM
Verastem Highlights AVMAPKI FAKZYNJA Strategy and Pipeline Risks
PremiumCompany Announcements
Verastem Highlights AVMAPKI FAKZYNJA Strategy and Pipeline Risks
1M ago
8K
VSTM
Verastem reports Q4 adjusted EPS (48c), consensus (50c)
PremiumThe FlyVerastem reports Q4 adjusted EPS (48c), consensus (50c)
1M ago
VSTM
Verastem announces upcoming key milestones
Premium
The Fly
Verastem announces upcoming key milestones
1M ago
VSTM
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
Premium
Market News
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
1M ago
UPB
VERA
VSTM Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
VSTM Upcoming Earnings Report: What to Expect?
2M ago
VSTM
Verastem price target raised to $18 from $15 at Mizuho
PremiumThe Fly
Verastem price target raised to $18 from $15 at Mizuho
2M ago
VSTM
3 ‘Strong Buy’ Stocks to Buy Now, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Now, According to Top Analysts
2M ago
AMZN
TTWO
Verastem reports preliminary Q4 revenue $17.5M, consensus $16.53M
PremiumThe Fly
Verastem reports preliminary Q4 revenue $17.5M, consensus $16.53M
2M ago
VSTM
Verastem Extends Cash Runway and Highlights 2025 Results
PremiumCompany AnnouncementsVerastem Extends Cash Runway and Highlights 2025 Results
2M ago
8K
VSTM
Verastem assumed with a Buy at H.C. Wainwright
Premium
The Fly
Verastem assumed with a Buy at H.C. Wainwright
2M ago
VSTM
Microvast, Datavault AI, RH, Becton Dickinson, Verastem Shake-Up
Premium
Weekend Updates
Microvast, Datavault AI, RH, Becton Dickinson, Verastem Shake-Up
3M ago
RH
BDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >